FGFR4 and metastatic malignant neoplasm: Next, the rate of FGFR4 mutations in metastatic cancer was examined in all patients from three recent sequencing studies: MSK-IMPACT,9,10 MET500,11 and Lefebvre et al.,12 as well as from sequencing data from Foundation Medicine.